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Aim To estimate the proportional contribution of influenza 
viruses (IV), parainfluenza viruses (PIV), adenoviruses (AV), 
and coronaviruses (CV) to the burden of severe acute low-
er respiratory infections (ALRI).
Methods The review of the literature followed PRISMA 
guidelines. We included studies of hospitalized children 
aged 0-4 years with confirmed ALRI published between 
1995 and 2011. A total of 51 studies were included in the 
final review, comprising 56 091 hospitalized ALRI episodes.
Results IV was detected in 3.0% (2.2%-4.0%) of all hospi-
talized ALRI cases, PIV in 2.7% (1.9%-3.7%), and AV in 5.8% 
(3.4%-9.1%). CV are technically difficult to culture, and they 
were detected in 4.8% of all hospitalized ALRI patients in 
one study. When respiratory syncytial virus (RSV) and less 
common viruses were included, at least one virus was de-
tected in 50.4% (40.0%-60.7%) of all hospitalized severe 
ALRI episodes. Moreover, 21.9% (17.7%-26.4%) of these vi-
ral ALRI were mixed, including more than one viral patho-
gen. Among all severe ALRI with confirmed viral etiology, 
IV accounted for 7.0% (5.5%-8.7%), PIV for 5.8% (4.1%-7.7%), 
and AV for 8.8% (5.3%-13.0%). CV was found in 10.6% of 
virus-positive pneumonia patients in one study.
Conclusions This article provides the most comprehen-
sive analysis of the contribution of four viral causes to 
severe ALRI to date. Our results can be used in further 
cost-effectiveness analyses of vaccine development and 
implementation for a number of respiratory viruses.
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Acute lower respiratory tract infections (ALRI) are the lead-
ing cause of global mortality in children under five years of 
age (1,2). Studies of pre-school children from developed 
and developing countries alike suggest that the majority 
of respiratory infections generally have viral etiology (2-4). 
Clinically, ALRIs can be divided into pneumonias and bron-
chiolitis (5,6). Differentiating those two conditions can be 
particularly difficult in younger children, who typically ex-
hibit less specific clinical symptoms (3,7-9). In high-income 
countries (HIC), pneumonia rarely causes deaths in children 
(10), although it continues to be a major cause of morbid-
ity and poses a significant economic burden (11). Bronchi-
olitis is characterized by a distressing pattern of symptoms: 
low-grade/absent fever progressing to cough, coryza, tac-
hypnoea, hyperinflation, chest retraction, and widespread 
crackles or wheezes (12). Bronchiolitis deaths are very rare 
in HIC (13,14), but children are at increased risk of recurrent 
wheezing and the data on mortality in low and middle in-
come countries (LMIC) are scarce (15).
Etiology of severe ALRI episodes is not well understood: 
limited contribution of the three major pathogens (S. 
pneumoniae, H. influenza, and respiratory syncytial virus) 
is established, but the role of other viruses has not been 
explored. The importance of viruses as major causes of 
ALRI is becoming increasingly apparent because the sen-
sitivity of detection techniques has greatly improved and 
new molecular tests increasingly replace conventional 
methods. The use of polymerase-chain reaction (PCR) 
now allows identification of viruses that have previously 
been difficult or impossible to culture. In the past decade, 
numerous novel respiratory viruses that can cause ALRI 
have been discovered, and new diagnostic methods for 
the use in high and low-resource settings alike are con-
tinuously evolving (3,16-20). It seems that the conven-
tional diagnostic methods have systematically underesti-
mated the role of viruses as causal pathogens in ALRI (3), 
and also that viruses are capable of causing severe, life-
threatening ALRI (3). The emergence of the severe acute 
respiratory syndrome (SARS), caused by a novel corona-
virus, and the avian influenza type A (H5N1) outbreak are 
good recent examples (16,20).
Impressive progress has been made in the last decade in 
increasing the global availability of vaccines against the 
main bacterial causes of ALRI – S. pneumoniae and H. influ-
enzae type B – leading to marked reductions in both hos-
pitalizations and deaths (21,22). This will lead to increased 
focus on viral causes and their prevention and manage-
ment. Strains of influenza type A and B viruses can be 
life threatening (3), although infection in the majority of 
young children is vaccine-preventable (23,24). Parainflu-
enza viruses (PIV) are the most common cause of croup in 
young children, with PIV1 and PIV3 also being the causes 
of severe bronchiolitis and pneumonia (3,4,25), but there 
are currently no licensed PIV vaccines. Adenoviruses (AV) 
have long been recognized as pathogens of the lower re-
spiratory tract that can be associated with severe or lethal 
lower respiratory tract infection (3,26,27) or bronchioli-
tis obliterans (28-31). Coronaviruses (CV) cause common 
cold and have been historically thought to be a very rare 
cause of ALRI (32), despite the fact that they sporadically 
caused catastrophic disease in livestock (33). The SARS-CV 
outbreak in 2003, which was a highly virulent zoonosis 
capable of human-to-human transmission, renewed the 
interest in CV as human pathogens (32). This led to a dis-
covery of two previously unrecognized CVs as causes of 
ALRI (16,17).
This study analyzed the available information on the role of 
four viruses (IV, PIV, AV, and CV), all of which have been his-
torically considered to be relatively uncommon causes of 
severe ALRI in hospitalized cases. Our study did not assess 
the role of common causes – RSV, S. pneumonia, and H. 
influenzae – because their roles have already been system-
atically characterized and well-established (34). We are not 
aware of any systematic analyses of the global prevalence 
of viruses in severe childhood ALRI. We aimed to assess the 
proportion of cases of severe ALRI with a viral etiology and 
explore the contribution of mixed viral infections and sep-
arate contributions of IV, PIV, AV, and CV to severe ALRI in 
children under five years of age.
MetHodS
This systematic review was carried out using the PRISMA 
and MOOSE protocols (35-37). These protocols have been 
developed to ensure standardized and replicable approach 
to systematic review of the available evidence on the bur-
den of specific health problems, the role of risk factors, or 
the effectiveness of available health interventions, and the 
unified reporting of the findings.
Literature search and inclusion criteria
A systematic literature review was performed using the 
search terms detailed in Supplementary online material. 
This was supplemented by hand searching of key on-
line journals and reference lists of selected papers. The 
search included the following databases: Medline, 
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EMBASE, CINAHL, Global Health Library, WHOLIS, LILACS, 
IndMed, AIM, SciELO, IMEMR, IMSEAR, WPRIM, and SIGLE 
(gray literature).
All studies included in the analysis reported on inpatients 
aged 0-4 years with a clinical diagnosis of community-
acquired ALRI, bronchiolitis, or pneumonia. Investigation 
of viral etiology was a requirement and the participants 
needed to be free of co-morbid conditions. Children ad-
mitted to emergency departments were excluded, and 
so were intensive care patients wherever data was not 
reported for all other inpatients in the hospital, to avoid 
potential bias. We included studies conducted between 
1995 and 2011 with a continuous study period of one year 
(or multiples of one year), to avoid effects of seasonality. 
Studies that relied solely on serology for diagnosis were 
excluded, because this method could not reliably differ-
entiate acute from past infections (38,39). Studies that 
were conducted during an epidemic or pandemic out-
break were also excluded.
Study selection and data extraction
Study selection was performed following the removal of 
duplicates. Authors were contacted by email in cases when 
study data were not published in an extractable form, to 
collect further details. Data were extracted for study loca-
tion, period of study, sample, diagnostic assay, clinical di-
agnosis, age range and median age of study population, 
potential etiological agents investigated, proportion of pa-
tients in whom no etiological diagnosis was found, viruses 
and bacteria detected, and age breakdown of patients by 
diagnosis where available (Figure 1).
Assessment of bias within studies
During the process of data extraction, information was 
drawn from each study on possible sources of bias that 
could affect the results, such as:
• Respiratory sample used (as there is no “gold standard;” 
samples from lower respiratory tract are preferable, but 
they require invasive procedures and are difficult to obtain 
without contamination from the upper airway; because of 
this, most studies consider nasopharyngeal aspirates for vi-
ral detection as acceptable, although acknowledging limi-
tations. Viruses detected in the upper airway of a patient 
with ALRI are not necessarily pathogens of the lower re-
spiratory tract);
• HIV co-infection (as this is known to increase the suscepti-
bility to ALRI and the rate of atypical infection) (40);
• Viral detection technique and timing (as there is large 
variability in the sensitivity of different techniques; viral 
culture can only reliably be used within 2 days of onset of 
acute rhinorrhea, when viable virus shedding is at its peak 
(41); PCR can be used much later, because it does not re-
quire viable viruses in the sample, offering much improved 
sensitivity, but also greatly increased rates of detection of 
benign co-infections).
Summary measures
Proportional contributions of IV, PIV, AV, and CV to severe 
ALRI and associated confidence intervals were derived 
through meta-analysis using StatsDirect software pack-
age (StatsDirect Ltd, Academic version 2.7.9., Cheshire, UK). 
Due to large variation in methodology and patient demo-
graphics between studies, random effects models were 
used in all analyses, as proposed by DerSimonian and Laird 
(42). Heterogeneity and bias analyses were also performed 
for all meta-analyses. All presented results were shown to 
be free of publication bias, as demonstrated using funnel 
plots and analysis methods proposed by Begg (43), Egger 
FIguRe 1. details of the systematic review and study selection 
process.
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(44), and Harbold (45). This triple approach represents ro-
bust protection from the sources of bias.
ReSuLtS
Fifty one studies meeting the inclusion criteria were in-
cluded in this review, including 56 091 episodes of severe 
hospitalized ALRI. Figure 2 presents geographical distri-
bution of the retained studies, Figure 3 shows proportion 
of studies investigating different viruses (any virus, RSV, 
IV, PIV, AV, CV), while Table 1 presents their basic charac-
teristics in terms of case definition, sample size, period of 
study, and diagnostic methods used (15,40,46-94). Only 
four studies investigated children hospitalized with ALRI 
for both bacterial and viral etiology (59,64,69,74) and only 
six studies reported HIV co-infection as their exclusion cri-
teria (15,58,59,63,64,86). A total of 19 studies were from 
high-income countries (95), investigating on average 6.5 
viruses per study, while studies in LMIC investigated 2.7 vi-
ruses (unpaired t test: P = 0.002). It seems likely that this dif-
ference reflects the fact that more tests are typically used 
in establishing diagnosis in high-income settings, without 
certainty over the causal role of all identified viral patho-
gens, and this may introduce systematic bias and hetero-
geneity between studies in HIC and LMIC.
Figure 4 presents the results of meta-analysis of the propor-
tion of children with severe ALRI aged 0-4 years in whom 
at least one virus was detected (including RSV). Only stud-
ies that investigated three or more viruses were included 
in this analysis – 7 studies in total. This is an arbitrary cut 
off: these studies were deemed sufficiently active in their 
approach to detect viral infection, although the final result 
is likely to under-estimate the true burden. Pooled pro-
portion was 50.4% (95% confidence interval [CI], 40.0% to 
60.7%), with I˛ (inconsistency) parameter estimate of 97.0% 
(95% CI, 96.0% to 97.7%) (Table 2).
FIguRe 2. geographic distribution of studies included in this review (N = 51).
FIguRe 3. Proportion of studies retained for the final analyses 
that investigated individual viruses: approximately half 
investigated influenza virus (IV), parainfluenza virus (PIV), and/
or adenovirus (AV), with no studies on coronavirus (CV) before 
the 2003 SARS-CV outbreak. twenty studies only described 
one viral agent (11 of these respiratory syncytial virus, RSV).
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tAbLe 1. A description of basic characteristics of the included studies (15,40,46-94)
Author and reference number Year Country
Case 
def.
Cases 
(n)
Period 
of study
Age 
range 
(months) Sample
diagnostic
assay
Viruses 
tested 
(n)
Aberle, J.H., et al. (46) 2005 Austria† LRTI‡  772 Oct 2000 - July 2004 <12 NPA PCR 5
Al-Toum, R., et al. (47) 2009 Jordan LRTI  141 Sep 2002 - Mar 2004 <24 NPA Culture 1
Avendano, L.F., et al. (48) 2003 Chile LRTI 4618 Jan 1989 - Dec 2000 <24 NPA IFA 1
Banerji, A., et al. (49) 2009 Canada† LRTI  121 Jan 2002 - Mar 2003 <24 NPA IFA and PCR 20
Bdour, S., et al. (50) 2001 Jordan LRTI  271 Jan 1997 - May 1999 <24 NPW IFA 1
Bedoya, V.I., et al. (51) 1996 Colombia LRTI  103 Apr 1994 - Apr 1995 <12 NPW IFA 1
Bharaj, P., et al. (52) 2010 India LRTI  181 Apr 2005 - Mar 2007 <62 NPA PCR 1
Bharaj, P., et al. (53) 2009 India LRTI  135 Apr 2005 - Mar 2007 <72 NPA PCR 20
Bolisetty, S., et al. (54) 2005 Australia† AB  167 Jan 2000 - Dec 2000 <24 NPA EIA and Culture 4
Calvo, C., et al. (55) 2010 Spain† AB  318 Sep 2005 - Aug 2008 <12 NPA PCR 16
Canducci, F., et al. (56) 2008 Spain† LRTI  230 Oct 2004 - Sep 2006 <24 NPA PCR 4
Carballal, G., et al. (57) 2000 Argentina LRTI 1304 Jan 1990 - Dec 1996 <24 NPA IFA 1
Carballal, G., et al. (58) 2001 Argentina LRTI 1234 Apr 1993 - Dec 1994 <60 NPA IFA 4
Cevey-Macherel, M., et al. * (59) 2009 Switzerland† CAP   99 Mar 2003 - Dec 2005 <60 NPA PCR 7
Chakravarti, A., et al. (60) 1995 India LRTI   45 Jul 1990 - Jun 1991 <24 NPA EIA 1
Chan, K.B., et al. (61) 1999 Malaysia LRTI 5691 Jan 1982 - Dec 1997 <24 NPA IFA and Culture 4
Charanjit, K., et al. (62) 2010 India AB  245 Jan 2007 - Dec 2007 <12 NPA/NPW PCR, EIA and Culture 6
Choi, E., et al. (63) 2006 Rep. Korea† LRTI  515 Sep 2000 - Aug 2005 <60 NPA PCR 11
Chong, C.Y., et al. * (64) 1997 Singapore† LRTI  333 May 1994 - Apr 1995 <60 NPA Not declared 4
Chung, T., et al. (65) 2007 Rep. Korea† LRTI  233 Jul 2004 - Jan 2006 <60 NPA PCR + IFA 7
Cifuentes, L., et al. (15) 2003 Chile AB   36 May 1999 - Aug 2000 <24 NPA EIA 1
Cilla, G., et al. (66) 2009 Spain † LRTI  533 Jul 2004 - Jun 2007 <35 NPA PCR 1
Dare, R.K., et al. (67) 2007 Thailand CAP  510 Sep 2003-Aug 2005 <60 NPS PCR and Culture 1
Djelantik, I.G., et al. (68) 2003 Indonesia LRTI 2677 Jan 2000 - Dec 2001 <24 NPW EIA 1
Ekalaksananan, T., et al. * (69) 2001 Thailand LRTI   62 Aug 1992 - Nov 1994 <60 NPA EIA and Culture 2
Fry, A.M., et al. (70) 2011 Thailand CAP  352 Sept 2003-Aug 2005 <60 NPS PCR and Culture 1
Fry, A.M., et al. (71) 2007 Thailand CAP  369 Sep 2004 - Aug 2005 <60 NPS PCR 1
Garcia, C.G., et al. (72) 2010 USA† AB 4285 Jan 2002 - Dec 2007 <23 NPA IFA and Culture 5
Kabra, S.K., et al. * (73) 2003 India LRTI   95 Mar 1995 - Feb 1997 <60 NPA Culture 4
Kabra, S.K., et al. (74) 2004 India LRTI  200 Mar 1995 - Feb 1997 <60 NPA Culture 4
Kim, Y.K., et al. (75) 2005 Rep. Korea† LRTI  166 Aug 1997 - Mar 2000 <60 NPA PCR 5
Loscertales, M.P., et al. (76) 2002 Mozambique LRTI 1001 Oct 1998 - May 2000 <60 NPA EIA 1
Moodley, T., et al. (40) 2010 S. Africa AB  106 Jan 2006 - Dec 2007 <24 NPA IFA 6
Moriyama, Y., et al. (77) 2010 Japan† LRTI  402 April 2007-July 2009 <24 NPS PCR 6
Nascimento-Carvalho, C.M., et 
al. (78)
2011 Brazil CAP  268 Sep 2003 - May 2005 <60 NPA PCR 1
Nokes, J., et al. (79) 2008 Kenya LRTI  223 Jan 2002 - Feb 2005 <30 NPA/NPW IFA 1
Nokes, J., et al. (80) 2009 Kenya CAP 6026 Jan 2002 - Dec 2007 <60 NPA/NPW IFA 1
O’Callaghan-Gordo, C., et al. (81) 2011 Mozambique CAP  807 Sep 2006 - Sep 2007 <60 NPA PCR 7
Oliveira, D.B., et al. (82) 2009 Brazil LRTI  226 Jan 2003 -Dec 2003 <60 NPA/NPS PCR 2
Samransamruajkit, R., et al. (83) 2008 Thailand CAP  239 Mar 2006-Feb 2007 <60 NPA PCR 1
Singleton, R.J., et al. (84) 2010 USA† LRTI  424 Oct 2005 - Sep 2007 <36 NPS/NPW PCR 4
Teeratakulpisarn, J., et al. (85) 2007 Thailand AB  170 Apr 2002 - Aug 2004 <24 NPA PCR 2
Videla, C., et al. (86) 1998 Argentina LRTI  158 May 1991-Dec 1992 <60 NPA IFA 2
Viegas, M., et al. (87) 2004 Argentina LRTI 18561 Jan 1998 - Dec 2002 <24 NPA IFA 4
Weber, M.W., et al. (88) 2002 Gambia LRTI 2252 Oct 1993 - Dec 1997 <60 NPA IFA 1
Weigl, J.A., et al. (89) 2005 Germany† CAP  187 Jul 1996 - Jun 2000 <60 NPA PCR 5
Wolf, D.G., et al. (90) 2006 Israel† CAP   88 Nov 2001 - Oct 2002 <60 NPW IFA and PCR 3
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Pneumonia and bronchiolitis
Bronchiolitis as a clinical diagnosis is useful in identify-
ing children who can be presumed unlikely to benefit 
from antibiotics. Pneumonia (especially focal) is known 
to have a different spectrum of etiological agents and an-
tibiotics are usually warranted. Six studies that differenti-
ate between these conditions were analyzed separately. 
The proportion of viruses detected in the bronchiolitis 
analysis was 66.3% (95% CI, 56.2% to 75.6%) and in the 
pneumonia analysis 48.7% (95% CI, 38.0% to 59.4%) (Ta-
ble 2).
Mixed viral ALRI
Seven studies investigated three or more viruses using 
PCR method and reported the proportion of hospitalized 
childhood ALRI where mixed viral infections were detected 
(ie, more than one viral pathogen was confirmed). A me-
ta-analysis of those studies showed that pooled propor-
tion was 15.3% (95% CI, 10.6%-20.5%), with I˛ parameter 
estimate of 91.3% (95% CI, 85.7%-94.0%). Further analysis, 
which only included virus-positive ALRI cases, estimated 
that at least 21.9% (95% CI, 17.7%-26.4%) of the viral ALRI 
were mixed (Figure 5).
Proportion of hospitalized ALRI due to influenza viruses
Meta-analysis included 9 studies in which IV infection was 
laboratory confirmed (Figure 6). We used only the 9 studies 
in which study population diagnosis was ALRI, rather than 
pneumonia or bronchiolitis separately. We estimated that 
3.0% (95% CI, 2.2%-4.0%) of hospitalized ALRI in children 
were due to IV, with I˛ parameter estimate of 89.1% (95% 
CI, 81.7%-92.6%). Further analysis was performed to 
quantify IV infection as a proportion of all viral ALRI; 
tAbLe 1. Continued. A description of basic characteristics of the included studies (15,40,46-94)
Author and reference number Year Country
Case 
def.
Cases 
(n)
Period 
of study
Age 
range 
(months) Sample
diagnostic
assay
Viruses 
tested 
(n)
Xepapadaki, et al. (91) 2004 Greece † AB   56 Oct 1999- Sep 2000 <24 NPW PCR 5
Xiang, Z., et al. (92) 2010 China CAP  384 Apr 2007-Mar 2008 <60 NPA PCR 1
Yin, C.C., et al. (93) 2003 Singapore† LRTI 1011 Aug 1998-Jul 1999 <60 NPA IFA 4
Yoo, S.J., et al. (94) 2007 Rep. Korea† LRTI  158 Jan 2004 - Dec 2004 <60 NPA PCR and IFA 7
*Studies that investigate viral and non-viral etiological agents.
†High income country, as classified by the global burden of disease (gbd21), excluding studies of indigenous groups.
‡Abbreviations: CAP – Community acquired pneumonia; Ab – acute bronchiolitis; LRtI – lower respiratory tract infection (or equivalent); NPA – na-
sopharyngeal aspirate; NPS – nasopharyngeal swab; NPW – nasopharyngeal wash; PCR – polymerase chain reaction; IFA – immunofluorescent assay; 
eIA – enzyme immuno-assay.
tAbLe 2. Summary of estimated proportions of influenza virus (IV), parainfluenza virus (PIV), and adenovirus (AV) in all hospitalized 
acute lower respiratory infections (ALRI) and viral hospitalized ALRI using meta-analysis of eligible studies.
Proportion (%)
95% confidence 
interval (%)
Proportion of all severe ALRI in children 0-4 y detecting:
influenza  3.0  2.2-4.0
parainfluenza  2.7  1.9-3.7
adenovirus  5.9  3.4-9.1
Proportion of children with severe ALRI aged 0-4 y in whom at least one virus was detected 
(including respiratory syncytial virus, RSV):
50.4 40.0-60.7
Proportion of children with severe bronchiolitis aged 0-4 y in whom at least one virus 
was detected (including RSV):
66.3 56.2-75.6
Proportion of children with severe pneumonia aged 0-4 y in whom at least one virus 
was detected (including RSV):
48.7 38.0-59.4
Proportion of viral severe ALRI in children 0-4 y detecting:
influenza  7.0  5.5-8.7
parainfluenza  5.8  4.1-7.7
adenovirus  8.8  5.4-13.0
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IV accounted for 7.0% (95% CI, 5.5%-8.7%), with I˛ param-
eter estimate of 77.3% (95% CI, 47.2%-87.0%) (Table 2).
Proportion of hospitalized ALRI due to parainfluenza 
viruses
Meta-analysis included 7 studies in which PIV infection was 
confirmed (Figure 7). Similarly to IV infection, we only in-
cluded those 7 studies where diagnosis was ALRI, rather 
than pneumonia or bronchiolitis separately. This analysis 
also excluded 3 studies where croup was a suspected di-
agnosis, because PIV are the major cause of croup. We es-
timated that 2.7% (95% CI, 1.9%-3.7%) of hospitalized ALRI 
in children were due to PIV, with I˛ parameter estimate of 
90% (95% CI, 82.0%-93.5%). Among all virus-positive hos-
pitalized ALRI cases, PIV accounted for 5.8% (95% CI, 4.1%-
7.7%), with I˛ parameter estimate of 85.4% (95% CI, 67.1%-
91.5%) (Table 2).
Proportion of hospitalized ALRI due to adenoviruses
Meta-analysis included 9 studies in which AV infection was 
confirmed (Figure 8). Similarly to IV infection, we only in-
cluded those 9 studies in which diagnosis was ALRI, rather 
than pneumonia or bronchiolitis separately. We estimated 
that 5.8% (95% CI, 3.4%-9.1%) of hospitalized ALRI in chil-
dren were due to AV, with I˛ parameter estimate of 98.2% 
(95% CI, 97.8%-98.5%). Among all virus-positive ALRI cases, 
AV accounted for 8.8% (95% CI, 5.3%-13.0%), with I˛ param-
eter estimate of 96.3% (95% CI, 94.9%-97.1%) (Table 2).
Proportion of hospitalized ALRI due to coronaviruses
The number of available studies on human CV was much 
smaller than on the other 3 viruses: 8 studies were retained 
after the initial review, but they did not provide sufficient 
epidemiological information on the role of CV to perform 
the meta-analysis and develop reliable estimates. CV are 
technically difficult to culture, and they were the sole vi-
rus detected in 4.8% of patients in one ALRI study (94) and 
were detected in 10.6% of virus-positive pneumonia pa-
tients in another study (59) (supplementary Figure).
dISCuSSIoN
This review estimated that 50% of all hospitalized ALRI 
in pre-school children, 66% of hospitalized bronciolitis 
episodes, and 49% of hospitalized pneumonia episodes 
showed viral involvement. All these estimates were de-
rived using very heterogeneous sets of studies (I2>90% in 
many analyses). This heterogeneity is not surprising, given 
the large differences in study methods used, participants’ 
ethnicity, climate and viral endemicity, to name a few. For 
this reason, random effects models were used, sacrificing 
statistical power to ensure estimates that would be as valid 
as realistically possible with available information.
In one third of the episodes of bronchiolitis in hospitalized 
patients, no virus could be detected, although bronchioli-
tis is expected to be almost exclusively of viral etiology. We 
FIguRe 5. Meta-analysis of the proportion of patients aged 0-4 years with severe 
acute lower respiratory infections (ALRI) in whom multiple viral infections were 
detected (asterisk denotes investigation by polymerase-chain reaction).
FIguRe 4. Meta-analysis of the proportion of patients aged 0-4 years with severe 
acute lower respiratory infections (ALRI) in whom a viral infection was detected 
(asterisk denotes investigation by polymerase-chain reaction).
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could hypothesize that this lack of sensitivity could be at-
tributed both to imperfections of the tests and the timing 
of obtaining the sample. It is also possible that, in some 
studies, the diagnostic process for bronchiolitis can include 
some asthmatic (non-viral) patients (12). If we assume that 
the etiological estimates for pneumonia are subject to the 
same lack of sensitivity, this would mean that our estimates 
are likely to present a lower bound of the true role of virus-
es in all ALRI, and that the likely direction of bias is toward 
under-estimation of the true burden of viruses.
Detection of viral etiologies in hospitalized ALRI has been 
markedly increased by the use of PCR. We estimated that 
multiple viruses were involved in at least 15.3% of all cases 
of ALRI and 21.9% of virus positive ALRI cases. Both of those 
figures are likely to be underestimates, because they were 
based on studies that only tested for a limited number of 
viruses, and not for all known viruses (96).
The analyzed studies might have been affected by differ-
ences in regional practice: there were subtle differences in 
defining criteria for bronchiolitis in different areas (12) and 
inter-observer reliability in assessing some clinical signs 
has been low (97). Furthermore, some regions are prone to 
classifying tracheobronchitis and croup as LRTIs. Accord-
ing to several textbooks of respiratory and pediatric medi-
cine these should be considered upper respiratory tract in-
fections (URTIs) (5,6), because the vocal cords are not the 
division between upper and lower airway. Surprisingly, no 
study included in this review detailed the study popula-
tions’ past vaccinations; in areas where vaccination against 
bacterial causes has been implemented, higher proportion 
of viral etiology would be expected. It also seems likely that 
a higher proportion of viral ALRI cases that are complicated 
by bacterial infection would be hospitalized than of those 
that are pure viral infections. It was beyond the scope of 
this study to consider virus seasonality or age breakdown 
for specific viral infections. In contrast to the other main 
respiratory viruses, PIV has been suggested to cause ALRI 
more frequently in summer months, while IV is thought to 
affect older children than RSV (3). Further work is necessary 
to elucidate these issues.
The delay between sample collection and establishing a 
diagnosis makes identifying causative agents of little prac-
tical use in the majority of acute cases of ALRI. Thus, good 
etiological epidemiology is important to guide manage-
ment. There is an argument, both economic and humani-
tarian, for prevention of viral ALRI over cure. Antiviral agents 
(with the possible exception of neuraminidase inhibitors 
for IV) have been shown largely ineffective. Following the 
successes of vaccination programs for bacterial ALRI, this 
review makes the case for the growing importance of viral 
agents and provides the first comprehensive estimates for 
the burden of viral etiology other than RSV.
Our study conveys some very broad and general mes-
sages for the further development of global health policy. 
FIguRe 6. Meta-analysis of the proportion of patients aged 0-4 years with severe 
acute lower respiratory infections (ALRI) in whom a laboratory confirmed influ-
enza infection was detected (asterisk denotes investigation by polymerase-chain 
reaction).
FIguRe 7. Meta-analysis of the proportion of patients aged 0-4 years with severe 
acute lower respiratory infections (ALRI) in whom parainfluenza infection was 
confirmed (asterisk denotes investigation by polymerase-chain reaction).
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First, there seems to be a viral etiological component to at 
least half of all severe ALRI that require hospitalization, and 
this number is probably an underestimate for the reasons 
discussed in this study. This is somewhat unexpected, be-
cause it establishes a larger role for viruses in severe ALRI 
than generally presumed in international health commu-
nity. Second, although RSV is a dominant viral cause, the 
role of influenza, parainfluenza, adenoviruses, and corona-
viruses should not be neglected: they seem to be jointly 
responsible for at least a third of all viral severe ALRI and 
one in six of all severe ALRI. Given that respiratory viruses 
are amenable to prevention through vaccination, and that 
their role at the community level is likely to be larger than 
at the hospital level, our study should allow for modeling 
of cost-effectiveness of developing such vaccines. With 
a global roll-out of the existing vaccines against S. pneu-
moniae and H. influenzae, viral etiology of ALRI will come 
under increased focus, and understanding the burden as-
sociated with particular viral pathogens should help plan 
global prevention and save further lives.
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